Amygdalar opioids modulate hypothalamic melanocortin-induced anorexia.

Area of Science:

• Neuroscience
• Endocrinology
• Behavioral Science

Background:

• The melanocortin system critically regulates satiety and feeding behavior.
• Opioid signaling influences appetite, with agonists increasing and antagonists decreasing food intake.
• The central amygdala (CeA) and paraventricular hypothalamus (PVN) are key brain regions in appetite control.

Purpose of the Study:

• To investigate if opioid activity in the CeA modulates melanocortin-induced feeding inhibition in the PVN.
• To explore the interplay between opioid and melanocortin systems in appetite regulation.

Main Methods:

• Utilized male Sprague-Dawley rats under food-deprived conditions.
• Administered melanotan II (MTII), a melanocortin agonist, into the PVN.
• Administered DAMGO (opioid agonist) and naltrexone (NTX, opioid antagonist) into the CeA.
• Measured food intake and c-Fos-immunoreactivity (IR) as indicators of neuronal activity.

Main Results:

• Intra-PVN MTII partially blocked the orexigenic effect of intra-CeA DAMGO.
• Co-injection of intra-CeA NTX with intra-PVN MTII significantly reduced food intake more than either agent alone.
• Intra-CeA NTX reduced c-Fos-IR in nucleus accumbens neurons.
• Intra-PVN MTII and co-injected intra-CeA NTX with intra-PVN MTII increased c-Fos-IR in PVN neurons.

Conclusions:

• Opioid actions within the CeA significantly modulate the feeding regulatory effects of melanocortins in the PVN.
• These findings highlight the role of the CeA-PVN pathway in a broader appetite regulatory network.
• The interaction between opioid and melanocortin systems is vital for integrating feeding and satiety signals.